BCM
RETA

Bayesian Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bayesian Capital Management’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-20,267
Closed -$616K – 1092
2022
Q2 		$616K Buy
+20,267
New +$616K 0.11% 270